한글목차

개요

세계 심방 내압 센서 임플란트 시장은 2023년 1,250만 달러에 달하고, 2031년에는 1,940만 달러에 달할 것으로 예상되며, 2024년부터 2031년까지 연평균 5.8%의 CAGR로 성장할 것으로 예상됩니다.

심방 내압 센서 임플란트는 심장의 압력을 모니터링하고 체액 축적 및 심장 기능 악화에 대한 데이터를 실시간으로 제공하는 의료기기입니다. 카테터나 외과적 시술을 통해 심방에 이식되는 이 생체 적합성 장치는 정확한 치료 조정을 가능하게 하여 입원을 예방하고 환자의 예후를 개선할 수 있습니다. 수집 된 데이터는 종종 의료 서비스 제공자에게 무선으로 전송되어 적시에 개입하고 심부전을 더 잘 관리 할 수 있습니다.

시장 역학:

촉진요인과 억제요인

심부전 유병률의 증가

전 세계적으로 심부전 유병률이 증가함에 따라 심방 내압 센서 임플란트와 같은 혁신적인 모니터링 솔루션에 대한 수요가 증가하고 있습니다. 심부전은 수백만 명에게 영향을 미치며 높은 이환율과 사망률과 관련이 있습니다. 의료 시스템은 이 질환을 더 잘 관리하고 모니터링할 수 있는 첨단 기술을 필요로 하고 있습니다. 심방 압력 센서 임플란트는 증상 악화를 감지하는 데 도움이 되는 실시간 데이터를 제공하여 적시에 개입하고 치료 계획을 조정할 수 있도록 돕습니다.

예를 들어, 미국심부전학회에 따르면 심부전은 미국에서 20세 이상 미국인 약 650만 명이 앓고 있으며, 전체 심장병 사망자의 8.5%를 차지할 정도로 미국에서 유행하는 질환입니다. 심장병 치료의 발전에도 불구하고 이 문제는 계속 확대되고 있으며, 매년 96만 명이 새롭게 심부전증을 앓고 있습니다. 심부전증은 주요 사망 원인으로, 의료 개선이 시급하다는 것을 강조하고 있습니다.

장치와 관련된 높은 비용

심방 내압 센서 임플란트 시장은 높은 비용, 제조 비용, 감염, 기기 오작동, 환자 불편과 같은 잠재적 합병증 등 여러 가지 문제에 직면해 있습니다. 이러한 높은 비용으로 인해 의료 예산이 압박을 받고 있으며, 규제 장벽과 임상시험으로 인해 새로운 기술의 도입이 지연될 수 있습니다.

또한, 심방 내압 센서의 장점과 기능에 대한 의료진과 환자들의 인식 부족은 심방 내압 센서의 채택을 저해할 수 있습니다. 이러한 요인들은 전체적으로 심방 내압 센서 임플란트 시장의 성장과 확장에 도전이 되고 있습니다.

목차

제1장 조사 방법과 조사 범위

제2장 정의와 개요

제3장 주요 요약

제4장 시장 역학

• 영향요인
  • 성장 촉진요인
    • 심부전 유병률 상승
    • 디바이스의 진보
  • 성장 억제요인
    • 디바이스 관련 고비용
  • 기회
  • 영향 분석

제5장 산업 분석

• Porter's Five Forces 분석
• 공급망 분석
• 가격 분석
• 규제 분석
• 특허 분석
• PESTLE 분석
• SWOT 분석
• DMI 오피니언

제6장 제품 유형별

• 이식형 센서
• 체외식 센서

제7장 용도별

• 심부전 관리
• 부정맥 검출
• 수술후 모니터링
• 기타

제8장 기술별

• 압력 센싱 기술
• 원격 모니터링 기술

제9장 최종사용자별

• 병원
• 심장 센터
• 재택의료
• 기타

제10장 지역별

• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 기타 유럽
• 남미
  • 브라질
  • 아르헨티나
  • 기타 남미
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 기타 아시아태평양
• 중동 및 아프리카

제11장 경쟁 상황

• 경쟁 시나리오
• 시장 상황/점유율 분석
• M&A 분석

제12장 기업 개요

• Vectorious
  • 기업 개요
  • 제품 포트폴리오와 설명
  • 재무 개요
  • 주요 발전
• Medtronic
• Boston Scientific
• Abbott Laboratories
• Cardiac Insight
• Biotronik
• Terumo Corporation

제13장 부록

영문목차

Overview

Global Atrial Pressure Sensor Implants Market reached US$ 12.5 million in 2023 and is expected to reach US$ 19.4 million by 2031, growing at a CAGR of 5.8% during the forecast period 2024-2031.

Atrial pressure sensor implants are medical devices that monitor heart pressure, providing real-time data on fluid buildup or worsening heart function. These biocompatible devices, implanted in the atrium through catheter or surgical procedures, enable precise treatment adjustments, prevent hospitalizations, and improve patient outcomes. The collected data is often transmitted wirelessly to healthcare providers, enabling timely interventions and better management of heart failure.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of heart failures

The increasing prevalence of heart failure worldwide is driving the demand for innovative monitoring solutions like atrial pressure sensor implants. Heart failure affects millions and is associated with high morbidity and mortality rates. Healthcare systems are seeking advanced technologies to better manage and monitor the condition. Atrial pressure sensor implants provide real-time data that can help detect worsening symptoms, allowing for timely interventions and adjustments to treatment plans.

For instance, according to the Heart Failure Society of America, heart failure is a prevalent issue in the United States, affecting nearly 6.5 million Americans over 20 and accounting for 8.5% of all heart disease deaths. Despite advancements in heart disease treatment, the problem continues to grow, with 960,000 new cases annually. Heart failure is a major killer, highlighting the urgent need for improved health care.

High costs associated with the devices

The atrial pressure sensor implant market faces several challenges, including high costs, manufacturing expenses, and potential complications like infection, device malfunction, and patient discomfort. Healthcare budgets are straining due to these high costs, and regulatory hurdles and clinical trials can delay the introduction of new technologies.

Additionally, lack of awareness among healthcare providers and patients about the benefits and functionalities of atrial pressure sensors may hinder their adoption. These factors collectively pose challenges to the growth and expansion of the atrial pressure sensor implant market.

Segment Analysis

The global atrial pressure sensor implants market is segmented based on product type, application, technology, end-user, and region.

The implantable sensors from the product type segment accounted for approximately 54.1% of the atrial pressure sensor implants market share

The implantable sensors from the product type segment accounted for approximately 54.1%. Implantable sensors in atrial pressure sensor implants are crucial for monitoring heart pressure in real-time, aiding in managing conditions like heart failure. They provide precise measurements, enabling clinicians to track disease progression, adjust treatment plans, and detect early signs of worsening symptoms. This continuous monitoring enhances patient care, enabling timely interventions and improved management of heart conditions.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like novel product launches, FDA approvals, expansions, increased healthcare infrastructure, and others that help the region to grow during the forecast period.

For instance, in June 2024, Tel Aviv-based startup Vectorious developed a pressure sensor implanted directly into the heart, allowing chronic heart failure patients to monitor their condition and treat it independently with a physician-approved response. The sensor measures the pressure in the left atrium, one of the heart's two upper chambers, and can identify increases caused by fluid buildup.

Market Segmentation

By Product Type

• Implantable Sensors
• External Sensors

By Application

• Heart Failure Management
• Arrhythmia Detection
• Post-Surgical Monitoring
• Others

By Technology

• Pressure Sensing Technology
• Remote Monitoring Technology

By End-User

• Hospitals
• Cardiac Centers
• Home Care Settings
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Vectorious, Medtronic, Boston Scientific, Abbott Laboratories, Cardiac Insight, Biotronik, and Terumo Corporation among others.

Key Developments

• In July 2024, Vectorious Medical Technologies Ltd. developed a miniature pressure sensor that is implanted within the heart via standard minimally invasive transvenous catheterization. The sensor measures Left Atrial Pressure (LAP), the earliest and most accurate indicator of fluid overload and congestion status. The system supports a scalable, physician-directed patient self-management approach, allowing heart failure (HF) patients to take an active role in managing their disease.

Why Purchase the Report?

• To visualize the global atrial pressure sensor implants market segmentation based on product type, application, technology, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the atrial pressure sensor implants market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global atrial pressure sensor implants market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by Technology
• 3.4. Snippet by End User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rise in the prevalence of heart failure
    • 4.1.1.2. Advancements in the devices
  • 4.1.2. Restraints
    • 4.1.2.1. High costs associated with the devices
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Patent Analysis
• 5.6. PESTLE Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Implantable Sensors*
  • 6.2.1. Introduction
• 6.3. External Sensors

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
• 7.2. Market Attractiveness Index, By Application
• 7.3. Heart Failure Management*
  • 7.3.1. Introduction
  • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.4. Arrhythmia Detection
• 7.5. Post-Surgical Monitoring
• 7.6. Others

8. By Technology

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
• 8.2. Market Attractiveness Index, By Technology
• 8.3. Pressure Sensing Technology*
  • 8.3.1. Introduction
  • 8.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.4. Remote Monitoring Technology

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Cardiac Centers
• 9.4. Home Care Settings
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. The U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. UK
    • 10.3.7.3. France
    • 10.3.7.4. Italy
    • 10.3.7.5. Spain
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Vectorious*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Medtronic
• 12.3. Boston Scientific
• 12.4. Abbott Laboratories
• 12.5. Cardiac Insight
• 12.6. Biotronik
• 12.7. Terumo Corporation

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us